Search results
BioAdaptives, Inc. Appoints James Keener as New CEO to Lead Strategic Growth Initiatives
NewMediaWire via Yahoo Finance· 7 hours agoLAS VEGAS, NV - (NewMediaWire) - May 21, 2024 - BioAdaptives, Inc. (OTC: BDPT), a pioneer in...
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
Zacks via Yahoo Finance· 1 day agoSee Stocks Free >> Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@zacks.com...
Boost Your Memory and Focus With These 5 Nootropic Herbs
Mercola· 1 day agoNootropics are sometimes called "smart drugs" since they enhance cognitive performance and especially executive functions like memory, focus and creativity. Nootropic herbs ...
ADDF invests $5 million in Coya Therapeutics for FTD treatment By Investing.com
Investing.com· 23 hours agoCoya Therapeutics, Inc. (NASDAQ:COYA), a biotech firm focusing on regulatory T cell therapies, has...
Modalert – A Comprehensive Overview for Cognitive Enhancement
Digital Journal· 20 hours agoAre you trying to improve memory, concentration and to reach your full potential in the workplace? If you have heard about this, you must be aware of the Modalert that is one of the most used ...
Conservative Family Scion Sentenced to Nearly 4 Years for Jan. 6 Attack
New York Times· 4 days agoLeo Brent Bozell, the son and grandson of influential right-wing figures, shattered a windowpane in...
Movano Health Reports Q1 2024 Financial Results and Provides Business Update
WKRN Nashville· 6 days agoMovano Health (Nasdaq: MOVE), a pioneer in health technology, reported first quarter 2024 results and provided a business update. Enhancing the Evie product experience, improving its operations ...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive via Yahoo Finance· 1 day agoKey Takeaways; Cannabis Sector Ayr Wellness reported solid first quarter results. Cresco Labs reported stagnant sales but an optimistic outlook for 2024. Tilray announced a $250 million equity ...
Earnings call: Eisai Co. Ltd. maintains steady revenue with a focus on Alzheimer's treatment By...
Investing.com· 4 days agoThe pharmaceutical giant emphasized its success with key products, especially in the Alzheimer's...
Lexaria (NASDAQ: LEXX) Partners with National Research Council of Canada for DehydraTECH-GLP-1...
Digital Journal· 6 days agoThe work program will utilize simulated gastric fluid, mimicking conditions in the human gut. In addition, various testing methods will be employed, among them size exclusion chromatography ...